NuVasive, Inc.

NuVasive, Inc.

NUVA

$39.75

Updated: 23/09/2026, 07:04:25

Market Cap
$2.08B
Sector
Healthcare
Industry
Medical - Devices
Country
US

No historical data available

Company Profile

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.

USD
NASDAQ
CEO: J. Christopher Barry
Employees: 3,000
https://www.nuvasive.com
Asset Summaries
Latest generated summaries for NUVA

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for NUVA.
Share price
$39.75
Market cap
$2.08B
Exchange
NASDAQ
Currency
USD
CEO
J. Christopher Barry
Employees
3,000
IPO date
13/05/2004
Beta
1.068929
Last dividend
$0.00
Day range
$39.51 – $40.96
52-week range
$35.17 – $49.53
1-day performance
-2.24%
1-year performance
13.02%
Current drawdown (1Y)
-19.75%
CIK
0001142596
CUSIP
670704105
ISIN
US6707041058
Created
07/12/2025, 05:31:48
Last update
23/09/2026, 07:04:25

Track NuVasive, Inc. with an AI analyst

See which prediction-market events move NUVA, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to NUVA from your Railway `news_articles` table.

No news found for this symbol.